1. Home
  2. CAL vs TRDA Comparison

CAL vs TRDA Comparison

Compare CAL & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$12.18

Market Cap

450.1M

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$11.36

Market Cap

404.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAL
TRDA
Founded
1878
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
450.1M
404.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CAL
TRDA
Price
$12.18
$11.36
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$14.00
$20.00
AVG Volume (30 Days)
628.6K
255.3K
Earning Date
03-19-2026
02-26-2026
Dividend Yield
2.29%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$2,702,018,000.00
$61,520,000.00
Revenue This Year
$5.63
N/A
Revenue Next Year
$2.16
$3.14
P/E Ratio
$19.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.54
$4.93
52 Week High
$19.42
$14.27

Technical Indicators

Market Signals
Indicator
CAL
TRDA
Relative Strength Index (RSI) 39.62 57.55
Support Level $12.03 $10.52
Resistance Level $12.80 $11.82
Average True Range (ATR) 0.61 0.74
MACD -0.18 0.03
Stochastic Oscillator 10.17 71.93

Price Performance

Historical Comparison
CAL
TRDA

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: